Facebook
X
LinkedIn
ForwardMarch 12, 2026: BCMA-Directed BsAbs in Multiple Myeloma: Overcoming Barriers to Care
Welcome to the fifth session of our ECHO program!
BCMA-Directed BsAbs in Multiple Myeloma: Overcoming Barriers to Care
Target Audience:
Oncologists, hematologists, PAs, NPs, nurses, nurse navigators, pharmacists and other healthcare professionals (HCPs) responsible for the care and treatment of people living with RRMM.
Please click on: Take Course the day of the session to access the zoom link.
Learning Objectives:
- Identify and categorize barriers to accessing BCMA-directed therapies for patients with multiple myeloma
- Discuss the impact of these barriers on health outcomes in various contexts
- Propose evidence-informed strategies and policy solutions to mitigate these barriers
Grantor Acknowledgement
This activity is supported by educational grants from Pfizer Inc., AbbVie Inc, and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Britney N. Bell, MD
Assistant Professor, Hematology/Oncology
Boston University Chobanian & Avedisian School of Medicine
Affiliate Faculty, Center for Forced Displacement
Boston University
Boston, MA
Britney N. Bell, MD, is a clinical researcher committed to advancing equitable cancer care by designing accessible, patient-centered solutions for historically marginalized communities. With a focus on human-centered design and implementation science, Bell develops innovative strategies to transform the patient experience and ensure care is tailored to diverse needs. Her work centers on expanding disease education across multiple contexts to enhance communication between patients, providers, and the healthcare system. She is especially passionate about applying these approaches to improve risk communication, foster community engagement, and build capacity for populations affected by hematologic diseases.
Dr. Britney Bell has no relevant financial relationships to disclose.
Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.
Accreditation Statement
This activity is developed as a joint collaboration among Boston University Chobanian & Avedisian School of Medicine, Med-IQ, the AAPA, the Association of PAs in Oncology (APAO), and HealthTree Foundation.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Accreditation
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine Maintenance of Certification (MOC) Part 2 Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By participating and claiming credit, you agree to BU sharing your information with ACCME PARS the data conduit to the ABIM.
Nurse Accreditation
Nursing Contact Hours: 1.0, of which 1.0 is eligible for pharmacology credit.
Pharmacist Accreditation
This activity is approved for 1.0 CPE credit.
Physician Associate Accreditation
Boston University Chobanian & Avedisian School of Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
Available Credit
- 1.00 AAPA Category I CME
- 1.00 ABIM Medical Knowledge
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC
- 1.00 ANCC Pharmacology
- 1.00 Participation
Thank you for registering for our first session!
Once you have participated in the meeting, click on the link provided in the chat or in your calendar invite to come back here. Click on "Take Course" above to complete the evaluation and claim credit.
Please contact [email protected] with any questions of if you need assistance.